Yew Bio-Pharm Group (YEWB) Stock Price, News & Analysis

Company Overview

Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People's Republic of China and the United States. It offers traditional Chinese medicine (TCM) raw materials in the form of yew tree branches and leaves to manufacture TCM containing taxol. The company is also involved in processing and selling yew raw materials used in the manufacture of traditional Chinese medicine; growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; manufacturing and selling furniture and handicrafts made of yew tree timber; selling agricultural products, such as yew candles, pine needle extracts, taxus cuspidate extracts, northeast yew extracts, and yew essential oil soaps; and selling wood ear mushroom. In addition, it engages in the marketing and sale of cosmetics. The company was incorporated in 2007 and is based in El Monte, California.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0002 to $0.0002
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

YEWB Stock Analysis - Frequently Asked Questions

How have YEWB shares performed this year?

Yew Bio-Pharm Group's stock was trading at $0.0002 at the beginning of 2025. Since then, YEWB stock has increased by 0.0% and is now trading at $0.0002.

How were Yew Bio-Pharm Group's earnings last quarter?

Yew Bio-Pharm Group Inc. (OTCMKTS:YEWB) released its earnings results on Tuesday, August, 14th. The company reported $0.03 earnings per share (EPS) for the quarter. The firm had revenue of $14.82 million for the quarter.

How do I buy shares of Yew Bio-Pharm Group?

Shares of YEWB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Yew Bio-Pharm Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Yew Bio-Pharm Group investors own include (PBIB) (PBIB), Goodyear Tire & Rubber (GT), Mood Media (MM), 3M (MMM), NASB Financial (NASB), LendingTree (TREE) and Tesla (TSLA).

Company Calendar

• Last Earnings: 8/14/2018
• Today: 7/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: AGRI OPERATIONS
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:YEWB
• CIK: 1548240
• Web: www.yewbiopharm.com
• Phone: (626) 401-9588
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A